Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Protein Import into the Peroxisomes01:27

Protein Import into the Peroxisomes

Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Mutations01:39

Mutations

Overview

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathomechanism of Fever-Induced Liver Failure in NBAS Deficiency and Treatment Effect of NAC-Observations In Vitro and In Vivo.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

Accelerating Leigh syndrome drug discovery through deep learning screening in brain organoids.

Nature communications·2026
Same author

Diagnostic Criteria and Management of MELAS and Stroke-Like Episodes: Consensus-Based Statements.

European journal of neurology·2026
Same author

Bi-allelic WDHD1 variants cause microcephalic primordial dwarfism.

American journal of human genetics·2026
Same author

Pluripotent stem-cell-based screening uncovers sildenafil as a mitochondrial disease therapy.

Cell·2026
Same author

Pediatric high-grade gliomas in patients with neurofibromatosis type 1-A collaborative cohort study from the SIOPE HGG/DIPG working group.

Neuro-oncology practice·2026

Related Experiment Videos

OXPHOS mutations and neurodegeneration.

Werner J H Koopman1, Felix Distelmaier, Jan A M Smeitink

  • 1Department of Biochemistry, Nijmegen Centre for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands. w.koopman@ncmls.ru.nl

The EMBO Journal
|November 15, 2012
PubMed
Summary
This summary is machine-generated.

Mitochondrial oxidative phosphorylation (OXPHOS) is vital for cellular energy. Mutations in OXPHOS genes cause neurodegenerative disorders like Leigh syndrome, highlighting OXPHOS dysfunction

Related Experiment Videos

Area of Science:

  • Cellular Biology
  • Biochemistry
  • Genetics

Background:

  • Mitochondrial oxidative phosphorylation (OXPHOS) is essential for cellular energy metabolism, involving complex protein machinery.
  • The OXPHOS system comprises 5 complexes (CI-CV) built from nuclear (nDNA) and mitochondrial (mtDNA) DNA-encoded proteins, plus assembly factors.
  • Mutations in OXPHOS genes lead to primary OXPHOS disorders, often manifesting as neurodegenerative diseases such as Leigh syndrome.

Purpose of the Study:

  • To review current knowledge on the function, biogenesis, regulation, and genetic basis of the OXPHOS system.
  • To catalog OXPHOS structural and assembly genes implicated in human neurodegenerative disorders.
  • To explore the cellular consequences of mutations in OXPHOS genes and their role in neurodegeneration.

Main Methods:

  • Literature review and synthesis of existing research on OXPHOS.
  • Inventory and classification of genes involved in OXPHOS structure and assembly.
  • Analysis of cellular impacts of OXPHOS gene mutations.

Main Results:

  • Detailed insights into OXPHOS system function, biogenesis, and regulation.
  • An updated inventory of OXPHOS genes linked to neurodegenerative diseases.
  • Understanding of how OXPHOS dysfunction at the cellular level contributes to neurodegeneration.

Conclusions:

  • OXPHOS gene mutations are a significant cause of neurodegenerative disorders.
  • Studying OXPHOS dysfunction provides critical insights into the mechanisms of neurodegeneration.
  • Further research into OXPHOS is crucial for understanding and potentially treating these diseases.